Alignment Healthcare ( ALHC ) announced the pricing of a public offering of 13,167,733 shares of its common stock by an affiliate of General Atlantic, L. P. The underwriter sold the shares at $19.46 each. Alignment Healthcare will not receive any proceeds from this sale. The offering is expected to close on March 4, 2026, pending standard closing conditions. More on Alignment Healthcare Alignment ...
Alignment Healthcare ( ALHC ) announced the pricing of a public offering of 13,167,733 shares of its common stock by an affiliate of General Atlantic, L. P. The underwriter sold the shares at $19.46 each. Alignment Healthcare will not receive any proceeds from this sale. The offering is expected to close on March 4, 2026, pending standard closing conditions. More on Alignment Healthcare Alignment Healthcare, Inc. (ALHC) Q4 2025 Earnings Call Transcript Alignment Healthcare, Inc. (ALHC) Presents at 44th Annual J.P. Morgan Healthcare Conference Transcript Alignment Healthcare GAAP EPS of -$0.05 beats by $0.10, revenue of $1.02B beats by $20M Medicare Advantage growth reportedly slows down as UnitedHealth, CVS retreat Seeking Alpha’s Quant Rating on Alignment Healthcare
Broadcom (AVGO +0.00%) may not get the attention of some of its peers in the technology sector, but make no mistake: the company is a key player in the space. Its products represent a broad cross-section of tech infrastructure and are a crucial part of the artificial intelligence (AI) revolution. Shareholders have been the ultimate beneficiaries as Broadcom leverages this opportunity, driving its ...
Broadcom (AVGO +0.00%) may not get the attention of some of its peers in the technology sector, but make no mistake: the company is a key player in the space. Its products represent a broad cross-section of tech infrastructure and are a crucial part of the artificial intelligence (AI) revolution. Shareholders have been the ultimate beneficiaries as Broadcom leverages this opportunity, driving its sales and profits higher. This, in turn, has driven its stock price up 437% over the past three years (as of this writing) and up 60% during the past 12 months. The company faces a key hurdle when Broadcom reports its fiscal 2026 first-quarter results after the market close on March 4. Given the stock's meteoric rise over the past year, should investors lay out their hard-earned money to buy shares ahead of this crucial financial report? Let's see what the evidence suggests. Chip shot Broadcom provides a wide array of technology solutions that reach into every nook and cranny of the industry. These diverse offerings include software, semiconductor, and security products serving the mobile, broadband, cable, and -- perhaps most importantly -- data center industries. The dawn of AI in early 2023 represented a singular opportunity, and Broadcom positioned itself to profit. The company's Application-Specific Integrated Circuits (ASICs) can be customized to accelerate AI workloads while being more energy-efficient than rival graphics processing units (GPUs). Broadcom also supplies many of the networking solutions that form the backbone of data center operations. This strategy has been lucrative for Broadcom. In its fiscal 2025 fourth quarter (ended Nov. 2), the company generated revenue of $18 billion, up 18% year over year, while its adjusted earnings per share (EPS) of $1.95 jumped 37%. AI semiconductor revenue led the charge, growing 74%. Management is predicting that the good times will continue. For the first quarter, Broadcom is guiding to revenue of $19.1 billion, represe...
Broadcom (AVGO +1.18%) may not get the attention of some of its peers in the technology sector, but make no mistake: the company is a key player in the space. Its products represent a broad cross-section of tech infrastructure and are a crucial part of the artificial intelligence (AI) revolution. Shareholders have been the ultimate beneficiaries as Broadcom leverages this opportunity, driving its ...
Broadcom (AVGO +1.18%) may not get the attention of some of its peers in the technology sector, but make no mistake: the company is a key player in the space. Its products represent a broad cross-section of tech infrastructure and are a crucial part of the artificial intelligence (AI) revolution. Shareholders have been the ultimate beneficiaries as Broadcom leverages this opportunity, driving its sales and profits higher. This, in turn, has driven its stock price up 437% over the past three years (as of this writing) and up 60% during the past 12 months. The company faces a key hurdle when Broadcom reports its fiscal 2026 first-quarter results after the market close on March 4. Given the stock's meteoric rise over the past year, should investors lay out their hard-earned money to buy shares ahead of this crucial financial report? Let's see what the evidence suggests. Chip shot Broadcom provides a wide array of technology solutions that reach into every nook and cranny of the industry. These diverse offerings include software, semiconductor, and security products serving the mobile, broadband, cable, and -- perhaps most importantly -- data center industries. The dawn of AI in early 2023 represented a singular opportunity, and Broadcom positioned itself to profit. The company's Application-Specific Integrated Circuits (ASICs) can be customized to accelerate AI workloads while being more energy-efficient than rival graphics processing units (GPUs). Broadcom also supplies many of the networking solutions that form the backbone of data center operations. This strategy has been lucrative for Broadcom. In its fiscal 2025 fourth quarter (ended Nov. 2), the company generated revenue of $18 billion, up 18% year over year, while its adjusted earnings per share (EPS) of $1.95 jumped 37%. AI semiconductor revenue led the charge, growing 74%. Management is predicting that the good times will continue. For the first quarter, Broadcom is guiding to revenue of $19.1 billion, represe...
TLDRs; Nvidia invests $2B in Lumentum to secure laser supply for expanding AI data centers. Multi-year partnership targets optical interconnects and co-packaged optics for energy-efficient AI networks. Lumentum sees record orders as Nvidia locks future capacity for advanced laser components. Nvidia’s AI infrastructure strategy shifts focus from compute to high-speed networking innovations. 💥 Find ...
TLDRs; Nvidia invests $2B in Lumentum to secure laser supply for expanding AI data centers. Multi-year partnership targets optical interconnects and co-packaged optics for energy-efficient AI networks. Lumentum sees record orders as Nvidia locks future capacity for advanced laser components. Nvidia’s AI infrastructure strategy shifts focus from compute to high-speed networking innovations. 💥 Find the Next KnockoutStock! Get live prices, charts, and KO Scores from KnockoutStocks.com , the data-driven platform ranking every stock by quality and breakout potential. Nvidia (NASDAQ: NVDA) shares surged following the announcement of a $2 billion investment in Lumentum Holdings Inc. (NASDAQ: LITE), a leading US manufacturer of lasers and optical components. The nonexclusive, multiyear agreement also includes multibillion-dollar purchase commitments, designed to secure long-term access to advanced laser technologies. The investment will support Lumentum’s research and development efforts and help finance the construction of a new fabrication facility in the United States. By expanding production capacity, Nvidia aims to ensure a steady supply of optical components critical for AI-driven data centers. Jensen Huang, Nvidia’s CEO, emphasized that artificial intelligence is driving the largest computing infrastructure buildout in history. He noted that the partnership with Lumentum will accelerate the development of silicon photonics and co-packaged optics, technologies that allow high-speed optical connections directly inside chip packages. Lumentum’s Strong Position Benefits from Nvidia Deal Unlike companies seeking financial bailouts, Lumentum is already growing rapidly. The company reported quarterly revenue of $665.5 million, up 65% year over year, with over 60% coming from AI and cloud infrastructure clients. NVIDIA Corporation, NVDA The new agreement also coincides with a record backlog for optical circuit switches, exceeding $400 million. These orders are expected to be...
Shares of Select Medical Holdings ( SEM ) rose in extended trading after the company announced a definitive agreement for a $3.9 billion acquisition. An entity affiliated with a consortium led by executive chairman Robert A. Ortenzio, senior executive VP Martin F. Jackson, and Welsh, Carson, Anderson & Stowe (WCAS) will acquire all outstanding shares not already owned by the group for $16.50 per s...
Shares of Select Medical Holdings ( SEM ) rose in extended trading after the company announced a definitive agreement for a $3.9 billion acquisition. An entity affiliated with a consortium led by executive chairman Robert A. Ortenzio, senior executive VP Martin F. Jackson, and Welsh, Carson, Anderson & Stowe (WCAS) will acquire all outstanding shares not already owned by the group for $16.50 per share in cash. The merger consideration represents a premium of approximately 18% over Select Medical's unaffected share price as of November 24, 2025, the last trading day prior to a publicly disclosed proposal being submitted by Ortenzio to the company's Board of Directors. The merger is expected to close in mid-2026 and is not subject to a financing condition, Select Medical Holdings ( SEM ) said . Shares in the company were up over 7% in post-market trading on Monday. More on Select Medical Select Medical Holdings Corporation (SEM) Q4 2025 Earnings Call Transcript Select Medical anticipates up to $5.8B revenue in 2026 while advancing inpatient rehab expansion Select Medical Non-GAAP EPS of $0.16 misses by $0.07, revenue of $1.4B beats by $40M Seeking Alpha’s Quant Rating on Select Medical Historical earnings data for Select Medical
Our multi-factor assessment suggests that it may be time to buy more shares of NVDA stock. We have, overall, a positive view of the stock, and a price of $236 may not be out of reach. We believe there is nothing to fear in NVDA stock given its overall Very Strong operating performance and financial condition. Hence, despite its Very High valuation, the stock appears Attractive but Volatile. Below ...
Our multi-factor assessment suggests that it may be time to buy more shares of NVDA stock. We have, overall, a positive view of the stock, and a price of $236 may not be out of reach. We believe there is nothing to fear in NVDA stock given its overall Very Strong operating performance and financial condition. Hence, despite its Very High valuation, the stock appears Attractive but Volatile. Below is our assessment: CONCLUSION What you pay: Valuation Very High What you get: Growth Very Strong Profitability Very Strong Financial Stability Very Strong Downturn Resilience Moderate Operating Performance Very Strong Stock Opinion Attractive but Volatile Portfolio beats stock-picking every time. Consider what could long-term performance for your portfolio be if you combined 10% commodities, 10% gold, and 2% crypto with equities. Let’s get into details of each of the assessed factors but before that, for quick background: With $4.4 Tril in market cap, NVIDIA provides graphics, compute, and networking solutions for gaming, visualization, datacenter, and automotive markets globally, with a strategic collaboration with Kroger Co. [1] Valuation Looks Very High NVDA S&P 500 Price-to-Sales Ratio 20.4 3.4 Price-to-Earnings Ratio 36.7 25.2 Price-to-Free Cash Flow Ratio 45.6 21.5 This table highlights how NVDA is valued vs broader market. For more details see: NVDA Valuation Ratios [2] Growth Is Very Strong NVIDIA has seen its top line grow at an average rate of 101.8% over the last 3 years over the last 3 years Its revenues have grown 65% from $130 Bil to $216 Bil in the last 12 months from $130 Bil to $216 Bil in the last 12 months Also, its quarterly revenues grew 73.2% to $68 Bil in the most recent quarter from $39 Bil a year ago. NVDA S&P 500 3-Year Average 101.8% 5.7% Latest Twelve Months* 65.5% 6.6% Most Recent Quarter (YoY)* 73.2% 7.6% This table highlights how NVDA is growing vs broader market. For more details see: NVDA Revenue Comparison [3] Profitability Appears Very Str...